1,299
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Quiescent stem cells in intestinal homeostasis and cancer

&
Pages 33-44 | Received 27 Jun 2011, Accepted 15 Aug 2011, Published online: 14 Sep 2011

References

  • Aguirre-Ghiso JA (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 7: 834–846.
  • Ahmed MA, Jackson D, Seth R, Robins A, Lobo Dn, Tomlinson Ip, and Ilyas M (2010). CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation. Inflamm Bowel Dis. 16: 795–803.
  • Balic M, Lin H, Young L, Hawes D, Giuliano A, Mcnamara G, Datar Rh, and Cote Rj (2006). Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res. 12: 5615–21.
  • Bao S, Wu Q, Mclendon RE, Hao Y, Shi Q, Hjelmeland Ab, Dewhirst Mw, Bigner Dd, and Rich Jn (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444: 756–60.
  • Barker N, Huch M, Kujala P, Van De Wetering M, Snippert HJ, Van Es JH, Sato T, Stange De, Begthel H, Van Den Born M, Danenberg E, Van Den Brink S, Korving J, Abo A, Peters PJ, Wright N, Poulsom R, and Clevers H (2010). Lgr5(+ ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 6: 25–36.
  • Barker N, Ridgway RA, Van Es JH Van De Wetering M, Begthel H, Van Den Born M, Danenberg E, Clarke AR, Sansom Oj, and Clevers H (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 457: 608–611.
  • Barker N, Van Es JH, Kuipers J, Kujala P, Van Den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, and Clevers H (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 449: 1003–1007.
  • Baumgart DC And Carding SR (2007). Inflammatory bowel disease: cause and immunobiology. Lancet. 369: 1627–1640.
  • Becker S, Becker-Pergola G, Wallwiener D, Solomayer EF, and Fehm T (2006). Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy. Breast Cancer Res Treat. 97: 91–96.
  • Becker S, Solomayer E, Becker-Pergola G, Wallwiener D, and Fehm T (2007). Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients. Breast Cancer Res Treat. 106: 239–243.
  • Bernstein CN, Blanchard JF, Kliewer E, and Wajda A (2001). Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 91:854–862.
  • Bickenbach JR (1981). Identification and behavior of label-retaining cells in oral mucosa and skin. J Dent Res. 60 Spec No C: 1611–1620.
  • Bjerknes M And Cheng H (1981). The stem-cell zone of the small intestinal epithelium. III. Evidence fromcolumnar, enteroendocrine, and mucous cells in the adult mouse. Am J Anat. 160: 77–91.
  • Brabletz T, Jung A, Spaderna S, Hlubek F, and Kirchner T (2005). Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer. 5: 744–9.
  • Braun S, Vogl Fd, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer Ef, Kundt G, Strobl B, Fehm T, Wong Gy, Bliss J, Vincent-Salomon A, and Pantel K (2005). A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 353: 793–802.
  • Breault Dt, Min IM, Carlone DL, Farilla LG, Ambruzs Dm, Henderson De, Algra S, Montgomery RK, Wagers AJ, and Hole N (2008). Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proc Natl Acad Sci U S A. 105: 10420–10425.
  • Brufsky A (2009). Trastuzumab-based therapy for patients with HER2-positive breast cancer: from early scientific development to foundation of care. Am J Clin Oncol. 33: 186–195.
  • Challen GA and Goodell MA (2008). Promiscuous expression of H2B-GFP transgene in hematopoietic stem cells. PLoS One. 3: e2357.
  • Cheng H And Leblond Cp (1974). Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat. 141: 537–561.
  • Cooper HS, Murthy SN, Shah RS, and Sedergran DJ (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 69: 238–249.
  • Cotsarelis G, Cheng SZ, Dong G, Sun TT, and Lavker Rm (1989). Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 57: 201–209.
  • Cotsarelis G, Sun TT, and Lavker RM (1990). Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 61:1329–1337.
  • Dembinski Jl And Krauss S (2009). Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastasis. 26: 611–623.
  • Diehn M, Cho Rw, Lobo Na, Kalisky T, Dorie Mj, Kulp An, Qian D, Lam Js, Ailles Le, Wong M, Joshua B, Kaplan Mj, Wapnir I, Dirbas Fm, Somlo G, Garberoglio C, Paz B, Shen J, Lau Sk, Quake Sr, Brown Jm, Weissman Il, and Clarke Mf (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 458:780–783.
  • Eaden Ja, Abrams Kr, and Mayberry Jf (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 48: 526–535.
  • Flores I, Canela A, Vera E, Tejera A, Cotsarelis G, and Blasco Ma (2008). The longest telomeres: a general signature of adult stem cell compartments. Genes Dev. 22: 654–67.
  • Foudi A, Hochedlinger K, Van Buren D, Schindler Jw, Jaenisch R, Carey V, and Hock H (2009). Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat Biotechnol. 27: 84–90.
  • Fox Dt And Spradling AC (2009). The Drosophila hindgut lacks constitutively active adult stem cells but proliferates in response to tissue damage. Cell Stem Cell. 5: 290–297.
  • Fuchs E (2009). The tortoise and the hair: slow-cycling cells in the stem cell race. Cell. 137: 811–819.
  • Galie M, Konstantinidou G, Peroni D, Scambi I, Marchini C, Lisi V, Krampera M, Magnani P, Merigo F, Montani M, Boschi F, Marzola P, Orru R, Farace P, Sbarbati A, and Amici A (2008). Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene. 27: 2542–251.
  • Gao MQ, Choi YP, Kang S, Youn JH, and Cho NH (2010). CD24 + cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene. 29: 2672–2680.
  • Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, and Mori M (2010). CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest. 120: 3326–3339.
  • Herfs M, Hubert P, and Delvenne P (2009). Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? Trends Mol Med. 15: 245–253.
  • Horan Pk, Melnicoff Mj, Jensen Bd, and Slezak Se (1990). Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol. 33: 469–490.
  • Hsu YC, Pasolli HA, and Fuchs E (2011). Dynamics between Stem Cells, Niche, and Progeny in the Hair Follicle. Cell. 144: 92–105.
  • Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, and Klein CA (2008). Systemic spread is an early step in breast cancer. Cancer Cell. 13: 58–68.
  • Imai T, Fukuta K, Hasumura M, Cho YM, Ota Y, Takami S, Nakagama H, and Hirose M (2007). Significance of inflammation-associated regenerative mucosa characterized by Paneth cell metaplasia and beta-catenin accumulation for the onset of colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine. Carcinogenesis. 28: 2199–2206.
  • Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, Fukata M, Miyamoto T, Lyons B, Ohshima K, Uchida N, Taniguchi S, Ohara O, Akashi K, Harada M, and Shultz LD (2007). Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 25: 1315–21.
  • Itzkowitz SH and Yio X (2004). Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 287: G7–G17.
  • Jaks V, Barker N, Kasper M, Van EE JH, Snippert HJ, Clevers H, and Toftgard R (2008). Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet. 40: 1291–1299.
  • Knutsen T, Mickley LA, Ried T, Green ED, Du Manoir S, Schrock E, Macville M, Ning Y, Robey R, Polymeropoulos M, Torres R, and Fojo T (1998). Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer. 23: 44–54.
  • Kusumbe AP and Bapat SA (2009). Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res. 69: 9245–53.
  • Lopez-Garcia C, Klein AM, Simons BD, and Winton DJ (2010). Intestinal stem cell replacement follows a pattern of neutral drift. Science. 330: 822–825.
  • Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, and Cotsarelis G (1998). The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci. 111 (Pt 21): 3179–3188.
  • Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, and Cotsarelis G (1999). Human hair follicle bulge cells are biochemically distinct and possess an epithelial stem cell phenotype. J Investig Dermatol Symp Proc. 4: 296–301.
  • Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou Ay, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LI, Polyak K, Brisken C, Yang J, and Weinberg RA (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133: 704–715.
  • May R, Riehl TE, Hunt C, Sureban SM, Anant S, and Houchen CW (2008) Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells, 26:630–637.
  • May R, Sureban SM, Hoang N, Riehl Te, Lightfoot SA, Ramanujam R, Wyche JH, Anant S, and Houchen CW (2009). Dcamkl-1 and LGR5 Mark Quiescent and Cycling Intestinal Stem Cells Respectively. Stem Cells, 10: 2571–2579.
  • Meira LB, Bugni JM, Green Sl, Lee CW, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, Mcfaline Jl, Schauer DB, Dedon PC, Fox JG, and Samson LD (2008) DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest. 118: 2516–2525.
  • Micchelli CA And Perrimon N (2006). Evidence that stem cells reside in the adult Drosophila midgut epithelium. Nature. 439: 475–479.
  • Mickley La, Spengler BA, Knutsen Ta, Biedler JI, and Fojo T (1997). Gene rearrangement: a novel mechanism for MDR-1 gene activation. J Clin Invest. 99: 1947–1957.
  • Montgomery RK, Carlone DI, Richmond CA, Farilla L, Kranendonk Me, Henderson DE, Baffour-Awuah NY, Ambruzs DM, Fogli Lk, Algra S, and Breault Dt (2011). Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A. 108: 179–184.
  • Morshead Cm, Reynolds BA, Craig CG, Mcburney MW, Staines Wa, Morassutti D, Weiss S, And Van Der Kooy D (1994). Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron. 13: 1071–1082.
  • Muller V, Alix-Panabieres C, and Pantel K (2010). Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies. Eur J Cancer. 46: 1189–1197.
  • Naumov Gn, Townson JI, Macdonald IC, Wilson Sm, Bramwell Vh, Groom Ac, and Chambers Af (2003). Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat. 82: 199–206.
  • Nishimura S, Wakabayashi N, Toyoda K, Kashima K, and Mitsufuji S (2003). Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci. 48: 1523–1529.
  • Ohlstein B and Spradling A (2006). The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature. 439: 470–474.
  • Pantel K and Brakenhoff RH (2004). Dissecting the metastatic cascade. Nat Rev Cancer. 4: 448–456.
  • Pantel K, Brakenhoff RH, and Brandt B (2008). Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 8: 329–340.
  • Paterson JC and Watson SH (1961). Paneth cell metaplasia in ulcerative colitis. Am J Pathol. 38: 243–249.
  • Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG, and Di Fiore PP (2010). Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 140: 62–73.
  • Porter EM, Bevins CI, Ghosh D, and Ganz T (2002). The multifaceted Paneth cell. Cell Mol Life Sci. 59: 156–170.
  • Potten CS (1998). Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci. 353: 821–830.
  • Potten CS, Booth C, Tudor GI, Booth D, Brady G, Hurley P, Ashton G, Clarke R, Sakakibara S-I, and Okano H (2003). Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation. 71: 28–41.
  • Potten CS, Owen G, and Booth D (2002). Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci. 115: 2381–2388.
  • Qiao XT, Ziel JW, Mckimpson W, Madison BB, Todisco A, Merchant JL, Samuelson LC, and Gumucio DL (2007). Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology. 133: 1989–1998.
  • Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, and Morrison SJ (2008). Efficient tumour formation by single human melanoma cells. Nature. 456: 593–598.
  • Reid BJ, Li X, Galipeau PC, and Vaughan TL (2010). Barrett’s oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer. 10: 87–101.
  • Reya T, Morrison SJ, Clarke MF, and Weissman IL (2001). Stem cells, cancer, and cancer stem cells. Nature. 414: 105–11.
  • Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, and Herlyn M (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 141: 583–594.
  • Roth S, Franken P, Van Veelen W, Blonden L, Raghoebir L, Beverloo B, Van Drunen E, Kuipers EJ, Rottier R, Fodde R, and Smits R (2009). Generation of a tightly regulated doxycycline-inducible model for studying mouse intestinal biology. Genesis. 47: 7–13.
  • Roth S, Franken PF, Sacchetti A, and Fodde R (2011). Identification of quiescent and multipotent intestinal Paneth-like cells that are activated in response to tissue injury. submitted.
  • Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, Najima Y, Takagi S, Aoki Y, Wake A, Taniguchi S, Shultz LD, and Ishikawa F (2010). Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol. 28: 275–280.
  • Sangiorgi E and Capecchi MR (2008). Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet. 40: 915–920.
  • Saphner T, Tormey DC, and Gray R (1996). Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 14: 2738–2746.
  • Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, Buyse M, Labianca R, Seitz JF, O’callaghan CJ, Francini G, Grothey A, O’connell M, Catalano PJ, Kerr D, Green E, Wieand HS, Goldberg RM, and De Gramont A (2007). End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol. 25: 4569–4574.
  • Sato T, Van Es JH, Snippert HJ, Stange DE, Vries RG, Van Den Born M, Barker N, Shroyer NF, Van De Wetering M, and Clevers H (2011). Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 469: 415–418.
  • Sato T, Vries RG, Snippert HJ, Van De Wetering M, Barker N, Stange De, Van Es JH, Abo A, Kujala P, Peters PJ, and Clevers H (2009). Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 459: 262–265.
  • Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, and Visvader JE (2006). Generation of a functional mammary gland from a single stem cell. Nature. 439: 84–88.
  • Slack JM (2009). Metaplasia and somatic cell reprogramming. J Pathol. 217: 161–168.
  • Snippert HJ, Van Der Flier LG, Sato T, Van Es JH, Van Den Born M, Kroon-Veenboer C, Barker N, Klein AM, Van Rheenen J, Simons BD, and Clevers H (2010). Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell. 143: 134–44.
  • Sommers SC (1966). Mast cells and paneth cells in ulcerative colitis. Gastroenterology. 51: 841–50.
  • Spotl L, Sarti A, Dierich MP, and Most J (1995). Cell membrane labeling with fluorescent dyes for the demonstration of cytokine-induced fusion between monocytes and tumor cells. Cytometry. 21: 160–9.
  • Steinert R, Vieth M, Hantschick M, and Reymond MA (2005). Epithelial cells disseminate into the bone marrow of colorectal adenoma patients. Gut. 54: 1045–6.
  • Takashima S, Mkrtchyan M, Younossi-Hartenstein A, Merriam JR, and Hartenstein V (2008). The behaviour of Drosophila adult hindgut stem cells is controlled by Wnt and Hh signalling. Nature. 454: 651–5.
  • Tanaka T, Kohno H, Suzuki R, Hata K, Sugie S, Niho N, Sakano K, Takahashi M, and Wakabayashi K (2006). Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/ +) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer. 118: 25–34.
  • Teng C, Guo Y, Zhang H, Zhang H, Ding M, and Deng H (2007). Identification and characterization of label-retaining cells in mouse pancreas. Differentiation. 75: 702–12.
  • Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, Moscatelli D, Shapiro E, Lepor H, Sun TT, and Wilson EL (2002). Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol. 157: 1257–65.
  • Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, and Fuchs E (2004). Defining the epithelial stem cell niche in skin. Science. 303: 359–63.
  • Van Der Flier LG, Van Gijn ME, Hatzis P, Kujala P, Haegebarth A, Stange DE, Begthel H, Van Den Born M, Guryev V, Oving I, Van Es JH, Barker N, Peters PJ, Van De Wetering M, and Clevers H (2009). Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell. 136: 903–12.
  • Wada R (2009). Proposal of a new hypothesis on the development of colorectal epithelial neoplasia: nonspecific inflammation–colorectal Paneth cell metaplasia—colorectal epithelial neoplasia. Digestion. 79: Suppl 1, 9–12.
  • Wada R, Yamaguchi T, and Tadokoro K (2005). Colonic Paneth cell metaplasia is pre-neoplastic condition of colonic cancer or not? J Carcinog. 4: 5.
  • Weiss L and Ward PM (1990). Contributions of vascularized lymph-node metastases to hematogenous metastasis in a rat mammary carcinoma. Int J Cancer. 46: 452–5.
  • Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, and Goodell MA (2002). Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 245: 42–56.
  • Westbrook AM, Szakmary A, and Schiestl RH (2010). Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res. 705: 40–59.
  • Wilson A, Laurenti E, Oser G, Van Der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E, Lio P, Macdonald HR, and TRUMPP A (2008). Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 135: 1118–29.
  • Xie T (2009). Stem cell in the adult Drosophila hindgut: just a sleeping beauty. Cell Stem Cell. 5: 227–8.
  • YUASA Y (2003). Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer. 3: 592–600.
  • Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, Poppleton H, Zakharenko S, Ellison DW, and Gilbertson RJ (2009). Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature. 457: 603–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.